Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Jones raising target from 3$ to 9$

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Aug 01, 2023 10:29am

75 Views

Post# 35566752

RE:Jones raising target from 3$ to 9$

Could it be they take in account a 25% dilution soon to be. Lets say 6M shares @ 2.25usd would net 13.5M - fees.... Add that to lets say 15M cash on hand... roughly 28M to cover the covenant and give a chance to buid upon to get to 30M for next year 30M payment to Marathon.

<< Previous

Bullboard Posts

Next >>

Boeing pleads guilty to conspiracy charge